Actively Recruiting

All Genders
NCT06151600

A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J

Led by Elpida Therapeutics SPC · Updated on 2026-01-22

20

Participants Needed

3

Research Sites

396 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a multicenter, longitudinal, prospective observational natural history study of subjects with a molecularly confirmed diagnosis of CMT4J. The study will enroll 20 subjects of any age into a uniform protocol for follow-up and evaluations. Subject visits will occur every 12 months + 4 weeks for up to 2 years.

CONDITIONS

Official Title

A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female, all ages
  • Molecularly confirmed diagnosis of CMT4J by a certified or equivalent lab
  • Genomic DNA mutation showing bi-allelic pathogenic or likely pathogenic variants in the FIG4 gene
  • Consent provided by patients 18 or older or by caregivers/guardians for younger or unable patients
  • Assent provided by patients younger than 18 who can give assent
  • Able and willing to comply with study protocol including travel and visits
Not Eligible

You will not qualify if you...

  • Known genetic abnormalities that confound the clinical phenotype
  • Current participation in an interventional or therapeutic study
  • Receipt of investigational drugs within 90 days before baseline
  • Prior or current gene or stem cell therapy treatment
  • Any diseases that interfere significantly with CMT4J assessment
  • Any other conditions judged by Investigator or Sponsor to make participation unsuitable or interfere with study completion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Stanford University

San Francisco, California, United States, 94305

Actively Recruiting

2

University of Iowa

Iowa City, Iowa, United States, 52242

Actively Recruiting

3

University of Texas Southwestern

Dallas, Texas, United States, 75390

Actively Recruiting

Loading map...

Research Team

R

Rachel Thomas, RN

CONTACT

K

Keith Gottlieb, Ph.D

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here